Fiji’s declaration of a national HIV emergency marks a critical shift from managing a concentrated outbreak to confronting a widening public-health crisis. The government is expanding testing and treatment, but the scale and causes of the surge remain contested.

The conservative account reports 2,016 new diagnoses in 2025, a 27% increase, and says officials estimate that one in 60 adults is living with HIV. It also highlights the crisis’s toll on children: 59 babies were born with HIV last year and 18 died before their first birthday. At the same time, it stresses that wider testing may have uncovered infections that previously went undetected. Authorities plan to expand “free, voluntary and confidential testing” alongside prevention medication and harm-reduction services for people who inject drugs.¹

The liberal account gives a slightly different figure—2,060 new diagnoses—and places greater emphasis on the broader social drivers of transmission. It links the surge to rising methamphetamine use, unsafe injecting, sexual transmission, stigma and inadequate access to clean needles and medical care. Citing UNAIDS, it says new infections increased twelvefold between 2010 and 2025, while only 39% of people living with HIV knew their status and just 22% were receiving antiretroviral treatment.²

Both perspectives agree that Fiji’s response must move beyond an outbreak-level approach. Health Minister Ratu Atonio Lalabalavu called the declaration necessary because “an urgent coordinated response” was required, while UNAIDS warned that “AIDS is not over.”² The key difference is emphasis: the first account foregrounds diagnosis and government intervention; the second presents a systemic crisis in which drug policy, sexual health, stigma and treatment access are inseparable. Fiji’s proposed needle-and-syringe programme may therefore be a test not only of medical capacity, but of political willingness to confront the conditions driving transmission.